In April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that th...

This is a platform created by IIT to closely understand the problems of the industry and showcase prominent research work by the students a...

Coronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.

The maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...

The company asserted that its decision to withdraw Abbott was based on “low commercial uptake” and this was reflected in the sales figures ...

The government is expected to hold discussions to decide on these requests only in February, a year after it first capped prices of these l...

Abbott publicly announced intentions to stop global sales of dissolvable scaffold ‘Absorb’, which has been mired in controversy for risks r...

Abbott’s move also comes while several regulators in different countries have scrutinised this scaffold, used in life saving procedures, ov...

The Indian Pharmacopoeia Commission in Ghaziabad is the national coordination centre for the materio vigilance programme.

The Central Drugs Standard Control Organization (CDSCO)'s note posted on its website cited "safety concerns" as the reason.

The development comes in the wake of several studies showing that bioresorbable cardiac stents are not only not superior to existing DES, b...

Unlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...

"Price capping will make stents more affordable and accessible to patients and new prices leave enough margins to the industry to grow," he...

Cardiologists told TOI on Thursday the bioresorbable vascular scaffold (BVS)— the fourth generation and most recent one that dissolves into...

The National Pharmaceutical Pricing Authority (NPPA) has also called for a meeting with the stakeholders to discuss the issue on January 24.

Bioresorbable scaffolds showed that the device might perform as well as a metallic stent clinically , but it also meant an “increased risk“...

The decision of the Department of Pharmaceuticals comes months after the Ministry of Health in July included stents in the National List of...